Clinical Trial Update: Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome [NA]

View source ↗

Summary

A completed clinical trial investigating lithium carbonate for osteoporosis-pseudoglioma syndrome, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis Pseudoglioma

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Osteoporosis Pseudoglioma | NA | Status: COMPLETED | Results posted: 2018-04-27